{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Birth defects",
      "Cardiac embryonic development",
      "Congenital heart disease",
      "Fetal echocardiography",
      "Folate"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "23751925",
  "DateCompleted": {
    "Year": "2014",
    "Month": "04",
    "Day": "21"
  },
  "DateRevised": {
    "Year": "2013",
    "Month": "09",
    "Day": "23"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2013",
        "Month": "06",
        "Day": "07"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.siny.2013.05.003",
      "S1744-165X(13)00033-4"
    ],
    "Journal": {
      "ISSN": "1878-0946",
      "JournalIssue": {
        "Volume": "18",
        "Issue": "5",
        "PubDate": {
          "Year": "2013",
          "Month": "Oct"
        }
      },
      "Title": "Seminars in fetal & neonatal medicine",
      "ISOAbbreviation": "Semin Fetal Neonatal Med"
    },
    "ArticleTitle": "Environmental origins of congenital heart disease: the heart-placenta connection.",
    "Pagination": {
      "StartPage": "245",
      "EndPage": "250",
      "MedlinePgn": "245-50"
    },
    "Abstract": {
      "AbstractText": [
        "Although the mammalian embryo is well protected in the uterus, environmental chemicals, drugs, and maternal nutritional imbalances can interfere with regulatory pathways directing placental and embryonic development early in gestation. Embryonic cells are most susceptible to environmental influences during cellular specification and differentiation stages. Because biochemical differentiation precedes morphological outcome often by days, the period of susceptibility to environmental chemicals expectedly precedes visible morphogenic effects. The cellular mechanisms by which drugs and other environmental factors disrupt embryonic development and induce cardiac abnormalities have remained undefined."
      ],
      "CopyrightInformation": "Copyright \u00a9 2013. Published by Elsevier Ltd."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "All Children's Hospital, Johns Hopkins Medicine, St Petersburg, FL, USA. Electronic address: aa4md@aol.com."
          }
        ],
        "LastName": "Huhta",
        "ForeName": "James",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Linask",
        "ForeName": "Kersti K",
        "Initials": "KK"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, Non-U.S. Gov't",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Semin Fetal Neonatal Med",
    "NlmUniqueID": "101240003",
    "ISSNLinking": "1744-165X"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Environmental Pollutants"
    },
    {
      "RegistryNumber": "935E97BOY8",
      "NameOfSubstance": "Folic Acid"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Dietary Supplements"
    },
    {
      "QualifierName": [
        "congenital",
        "etiology",
        "physiopathology",
        "prevention & control"
      ],
      "DescriptorName": "Environmental Illness"
    },
    {
      "QualifierName": [
        "toxicity"
      ],
      "DescriptorName": "Environmental Pollutants"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Fetal Development"
    },
    {
      "QualifierName": [
        "drug effects",
        "physiopathology"
      ],
      "DescriptorName": "Fetal Heart"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Folic Acid"
    },
    {
      "QualifierName": [
        "embryology",
        "etiology",
        "physiopathology",
        "prevention & control"
      ],
      "DescriptorName": "Heart Defects, Congenital"
    },
    {
      "QualifierName": [
        "embryology",
        "etiology",
        "physiopathology",
        "prevention & control"
      ],
      "DescriptorName": "Heart Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infant, Newborn"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Maternal Exposure"
    },
    {
      "QualifierName": [
        "drug effects",
        "physiopathology"
      ],
      "DescriptorName": "Placenta"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pregnancy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prenatal Nutritional Physiological Phenomena"
    }
  ]
}